Carcinogens or Mutagens at Work (Amendment) Regulations, 2024
Table of Provisions (15)
Statutory Text (15 Articles)
L.N. 102 of 2024
OCCUPATIONAL HEALTH AND SAFETY AUTHORITY ACT
(CAP. 424)
Protection of Workers from the Risks related to Exposure to
Carcinogens or Mutagens at Work (Amendment) Regulations, 2024
IN EXERCISE of the powers conferred by article 12 of the
Occupational Health and Safety Authority Act, the Minister
responsible for occupational health and safety, after seeking the advice
of the Occupational Health and Safety Authority, has made the
following regulations:-
The title of these regulations is the Protection of Workers Citation.
from the Risks related to Exposure to Carcinogens or Mutagens at
Work (Amendment) Regulations, 2024, and these regulations shall be
read and construed as one with the Protection of Workers from the
Risks related to Exposure to Carcinogens or Mutagens at Work S.L. 424.22.
Regulations, hereinafter referred to as the "principal regulations".
Regulation 1 of the principal regulations shall be amended Amends
by the following
regulation 1 of
the principal
regulations.
(a) in the title thereof the words "the Risks related to
Exposure to Carcinogens or Mutagens" shall be substituted by
the words "the Risks related to Exposure to Carcinogens,
Mutagens or Reprotoxic Substances";
(b) sub-regulation (2) thereof shall be substituted by the
following new sub-regulation
"(2) These regulations have as their objective the
protection of workers against risks to their health and
safety, arising from or are likely to result from exposure to
carcinogens, mutagens or reprotoxic substances at the
workplace, including prevention of such risks.";
(c) sub-regulation (3) thereof shall be substituted by the
following new sub-regulation
"(3) These regulations shall apply to activities in
which workers are or are likely to be exposed to
carcinogens, mutagens or reprotoxic substances as a result
of their work."; and
(d) sub-regulation (6) thereof shall be substituted by the
following new sub-regulation
"(6)
The purpose of these regulations is to
transpose
(a) Directive 2004/37/EC of the European
Parliament and of the Council of 29 April 2004 on the
protection of workers from the risks related to
exposure to carcinogens, mutagens or reprotoxic
substances at work (Sixth individual Directive within
the meaning of Article 16(1) of Council Directive 89/
391/EEC); and
(b) Directive 2014/27/EU of the European
Parliament and of the Council of 26 February 2014
amending Council Directives 92/58/EEC, 92/85/EEC,
94/33/EC, 98/24/EC and Directive 2004/37/EC of the
European Parliament and of the Council, in order to
align them with Regulation (EC) No 1272/2008 on
classification, labelling and packaging of substances
and mixtures; and
(c) Directive (EU) 2017/2398 of the
European Parliament and of the Council of 12
December 2017 amending Directive 2004/37/EC on
the protection of workers from the risks related to
exposure to carcinogens or mutagens at work; and
(d) Directive (EU) 2019/130 of the European
Parliament and of the Council of 16 January 2019
amending Council Directive 2004/37/EC on the
protection of workers from the risks related to
exposure to carcinogens or mutagens at work; and
(e) Directive (EU) 2019/983 of the European
Parliament and of the Council of 5 June 2019
amending Directive 2004/37/EC on the protection of
workers from the risks related to exposure to
carcinogens or mutagens at work; and
(f) Directive (EU) 2022/431 of the European
Parliament and of the Council of 9 March 2022
amending Directive 2004/37/EC on the protection of
workers from the risks related to exposure to
carcinogens or mutagens at work.".
Regulation 2 of the principal regulations shall be amended Amends
regulation 2 of
by the following
the principal
regulations.
(a)
immediately after the definition "Authority" thereof
there shall be added the following new definition
" "biological limit value" means the limit of the
concentration in the appropriate biological medium of the
relevant agent, its metabolite, or an indicator of effect";
(b)
immediately after paragraph (a) of the definition
"carcinogen" thereof there shall be added the following new
paragraphs
"(ba) "reprotoxic substance" means a substance or
mixture, which meets the criteria for classification as a
category 1A or 1B reproductive toxicant set out in Annex I
to Regulation (EC) No 1272/2008 of the European
Parliament and of the Council of 16 December 2008 on
classification, labelling and packaging of substances and
mixtures, amending and repealing Directives 67/548/EEC
and 1999/45/EC, and amending Regulation (EC) No 1907/
2006;
(bb) "non-threshold reprotoxic substance" means a
reprotoxic substance to which there is no safe level of
exposure for workers’ health and which is identified as
such in the notation column of Schedule III;
(bc) "threshold reprotoxic substance" means a
reprotoxic substance for which a safe level of exposure
exists below which there is no risk to workers’ health and
which is identified as such in the notation column of
Schedule III;";
(c)
immediately after the definition "doctor" thereof
there shall be added the following new definition
" "health surveillance" means the assessment of an
individual worker to determine the state of health of that
individual, as related to exposure to specific carcinogens,
mutagens or reprotoxic substances at work."; and
(d) the definition "limit value" thereof
shall
be
substituted by the following new definition
" "limit value" means, unless otherwise specified, the
limit of the time-weighted average of the concentration for
a carcinogen, mutagen or reprotoxic substance in the air
within the breathing zone of a worker in relation to a
specified reference period as set out in Schedule III;".
Regulation 3 of the principal regulations shall be amended
by the following
(a) sub-regulation (1) thereof shall be substituted by the
following new sub-regulation
"(1) In the case of any activity likely to involve a
risk of exposure to carcinogens, mutagens or reprotoxic
substances, the nature, degree and duration of workers’
exposure shall be determined in order to make it possible to
assess any risk to the workers’ health or safety and to lay
down the measures to be taken. The assessment shall be
renewed regularly and in any event when any change
occurs in the conditions which may affect workers’
exposure to carcinogens, mutagens or reprotoxic
substances. The employer must supply the Authority at its
request with the information used for making the
assessment."; and
(b) sub-regulation (3) thereof shall be substituted by the
following new sub-regulation
"(3) When the risk assessment is carried out,
employers shall give particular attention to any effects
concerning the health or safety of workers at particular risk
and shall, inter alia, take account of the desirability of not
employing such workers in areas where they may come into
contact with carcinogens, mutagens or reprotoxic
substances.".
Sub-regulation (1) of regulation 4 of the principal
regulations shall be substituted by the following new sub-regulation
"(1) The employer shall reduce the use of a carcinogen,
mutagen or reprotoxic substance at the place of work, in
particular by replacing it, in so far as is technically possible, by a
substance, mixture or process which, under its conditions of use,
is not dangerous or is less dangerous to workers’ health or safety,
as the case may be.".
Sub-regulations (2), (3), (4) and (5) of regulation 5 of the
principal regulations shall be substituted by the following new sub-
regulations
"(2) Where it is not technically possible to replace the
carcinogen, mutagen or reprotoxic substance by a substance,
mixture or process which, under its conditions of use, is not
dangerous or is less dangerous to health or safety, the employer
shall ensure that the carcinogen, mutagen or reprotoxic substance
is, in so far as is technically possible, manufactured and used in a
closed system.
(3) Where a closed system is not technically possible, the
employer shall ensure that the level of exposure of workers to the
carcinogen, mutagen or non-threshold reprotoxic substance is
reduced to as low a level as is technically possible.
(3A) Where it is not technically possible to use or
manufacture a threshold reprotoxic substance in a closed system,
the employer shall ensure that the risk related to the exposure of
workers to that threshold reprotoxic substance is reduced to a
minimum.
(3B) The employer shall, with regard to reprotoxic
substances other than non-threshold reprotoxic substances and
threshold reprotoxic substances, apply sub-regulation (3A). In
such a case, when carrying out the risk assessment referred to in
regulation 3, the employer shall duly take into account the
possibility that a safe level of exposure for workers’ health for
such a reprotoxic substance might not exist and shall lay down
appropriate measures in that regard.
(4)
Exposure shall not exceed the limit value of a
carcinogen, mutagen or a reprotoxic substance as set out in
Schedule III.
(5) Wherever a carcinogen, mutagen or reprotoxic
substance is used, the employer shall apply all the following
measures
(a) limitation of the quantities of a carcinogen,
mutagen or reprotoxic substance at the place of work;
(b) keeping as low as possible the number of
workers exposed or likely to be exposed;
(c) design of work processes and engineering
control measures so as to avoid or minimise the release of
carcinogens, mutagens or reprotoxic substances into the
place of work;
(d) evacuation of carcinogens, mutagens or
reprotoxic substances at source, local extraction system or
general ventilation, all such methods to be appropriate and
compatible with the need to protect public health and the
environment;
(e) use of existing appropriate procedures for the
measurement of carcinogens, mutagens or reprotoxic
substances, in particular for the early detection of abnormal
exposures resulting from an unforeseeable event or an
accident;
(f) application of suitable working procedures and
methods;
(g) collective protection measures and, or, where
exposure may not be avoided by other means, individual
protection measures;
(h) hygiene measures, in particular regular cleaning
of floors, walls and other surfaces;
(i)
information for workers;
(j) demarcation of risk areas and use of adequate
warning and safety signs including "no smoking" signs in
areas where workers are exposed or likely to be exposed to
carcinogens, mutagens or reprotoxic substances;
(k) drawing up plans to deal with emergencies
likely to result in abnormally high exposure;
(l) means for safe storage, handling and
transportation, in particular by using sealed and clearly and
visibly labelled containers;
(m) means for safe collection, storage and disposal
of waste by workers, including the use of sealed and clearly
and visibly labelled containers.".
Paragraphs (a) and (b) of regulation 6 of the principal
regulations, shall be substituted by the following
"(a) the activities and, or industrial processes carried out,
including the reasons for which carcinogens, mutagens or
reprotoxic substances are used;
(b)
the quantities of substances or mixtures manufactured
or used which contain carcinogens, mutagens or reprotoxic
substances;".
Sub-regulation (1) of regulation 10 of the principal Amends
regulations shall be amended by the following
regulation 10 of
the principal
regulations.
(a) the words "Employers shall be obliged, in the case of
all activities for which there is a risk of contamination by
carcinogens or mutagens, to take appropriate measures to ensure
that" thereof shall be substituted by the words "Employers shall
be obliged, in the case of all activities for which there is a risk of
contamination by carcinogens, mutagens or reprotoxic
substances, to take appropriate measures to ensure that:"; and
(b) paragraph (a) thereof shall be substituted by the
following new paragraph
"(a) workers do not eat, drink or smoke in working
areas where there is a risk of contamination by carcinogens,
mutagens or reprotoxic substances;".
Regulation 11 of the principal regulations shall be amended Amends
by the following
regulation 11 of
the principal
regulations.
(a)
in sub-regulation (1) thereof the words "The training
shall be
- adapted to take account of new or changed risk, and
- repeated periodically if necessary." shall be substituted by
the words
"The training shall be
(i) adapted to take account of new or changed risk,
in particular when workers are or likely to be exposed to
new carcinogens, mutagens or reprotoxic substances or to a
number of different carcinogens, mutagens or reprotoxic
substances, including those contained in hazardous
medicinal products, or in case of changing circumstances
related to work,
(ii) provided periodically in healthcare settings to
all workers who are exposed to carcinogens, mutagens or
reprotoxic substances, in particular where new hazardous
medicinal products containing those substances are used,
and
(iii) repeated periodically in other settings if
necessary."; and
(b) sub-regulation (2) thereof shall be substituted by the
following new sub-regulation
"(2) Employers shall inform workers of installations
and related containers containing carcinogens, mutagens or
reprotoxic substances, ensure that all containers, packages
and installations containing carcinogens, mutagens or
reprotoxic substances are labelled clearly and legibly, and
display clearly visible warning and hazard signs.
Where a biological limit value has been set out in
Schedule IV, health surveillance shall be mandatory for
working with the carcinogen, mutagen or reprotoxic
substance in question, in accordance with the procedures
laid down in that Schedule. Workers shall be informed of
that requirement before being assigned to the task
involving the risk of exposure to the carcinogen, mutagen
or reprotoxic substance indicated.".
Regulation 14 of the principal regulations shall be amended
by the following
(a) sub-regulation (3) and (4) thereof shall be substituted
by the following new sub-regulations
"(3) If a worker is found to be suffering from an
abnormality which is suspected to be the result of exposure
to carcinogens, mutagens or reprotoxic substances, or if a
biological limit value is found to have been exceeded, the
doctor or authority responsible for the health surveillance
of workers may require other workers who have been
similarly exposed to undergo health surveillance.
(4)
In cases where health surveillance is carried
out, an individual medical record shall be kept and the
doctor or authority responsible for health surveillance shall
propose any protective or preventive measures to be taken
in respect of any individual workers. Biological monitoring
and related requirements may form part of health
surveillance."; and
(b) sub-regulation (8) thereof shall be substituted by the
following new regulation
"(8) All cases of cancer, adverse effects on sexual
function and fertility in adult male and female workers or
developmental toxicity in their offspring identified in
accordance with national law or practice as resulting from
occupational exposure to a carcinogen, mutagen or
reprotoxic substance shall be notified to the competent
authority.".
Sub-regulation (1) of regulation 15 of the principal Amends
regulations, shall be substituted by the following new sub-regulations: regulation 15 of
the principal
regulations.
"(1) With regard to carcinogens and mutagens, the list
referred to in paragraph (c) of regulation 12, and the medical
record referred to in regulation 14(4) shall be kept for at least
forty (40) years following the end of exposure, in accordance
with national law or practice.
(1A). With regard to reprotoxic substances, the list referred
to in paragraph (c) of regulation 12, and the medical record
referred to in regulation 14(4) shall be kept for at least five (5)
years following the end of exposure, in accordance with national
law or practice.".
Item 1 of Schedule II to the principal regulations shall be Amends
substituted by the following new item
Schedule II to the
principal
regulations.
"1. The doctor and, or authority responsible for the health
surveillance of workers exposed to carcinogens, mutagens or
reprotoxic substances shall be familiar with the exposure
conditions or circumstances of each worker.".
Schedule III to principal regulations shall be substituted by Substitutes
the following new Schedule
Schedule III to
the principal
regulations.
"
Name of
EC No CAS No Limit values
Notation Transi-
Short-term
8 hours ( 3 )
agent
tional
( 1 )
( 2 )
measures
( )
ppm f/ml mg/ pp f/ml
mg/m 3
( 6 ) ( 7 ) m3 m ( 7 )
( 5 )
( 5 ) ( 6)
Hardwood
-
-
-
Limit
2 ( 8 )
dusts
value
3 mg/m3
until 17
January
Chromium -
-
0.005
-
-
-
-
-
-
Limit
(VI) com-
value
pounds which
0.010 mg/
are carcino-
m3 until 17
gens within
January
the meaning
of paragraph
(a) of the
Limit
defenition
value
"carcinogen"
0.025 mg/
in regulation
m3 for
welding or
(as chro-
plasma cut-
mium)
ting pro-
cesses or
similar
work pro-
cesses that
generate
fume until
17 January
Refractory -
-
-
-
0.3 -
-
-
-
-
ceramic fibres
which are car-
cinogens
within the
meaning of
paragraph (a)
of definition
"carcinogen"
in regulation
Respirable
-
-
-
-
-
-
-
-
-
0.1 ( 9 )
crystalline sil-
ica dust
Benzene
200- 71-43-2 0.66
0.2 -
-
-
-
skin (10) Limit value
753-7
of 1ppm
(3.25 mg/
m3) until 5
April 2024.
Limit value
of 0,5 ppm
(1.65 mg/
m 3 ) from 5
April 2024
until 5
April 2026.
Vinyl chloride 200- 75-01-4 2.6
-
-
-
-
-
-
monomer
831-0
Ethylene
200- 75-21-8 1.8
-
-
-
-
skin (10) -
oxide
849-9
1,2- Epoxy- 200- 75-56-9 2.4
-
-
-
-
-
-
propane
879-2
Trichloroeth- 201- 79-01-6 54.7
-
164 30 -
skin (10) -
ylene
167-4
.1
Acrylamide 201- 79-06-1 0.1
-
-
- - -
skin (10) -
173-7
2-Nitropro- 201- 79-46-9 18
-
-
-
-
-
-
pane
209-1
o-Toluidine 202- 95-53-4 0.5
0.1 -
-
-
-
skin (10) -
429-0
4,4’-Methyl- 202- 101-77-9 0.08
-
-
-
-
-
skin (10) -
enedianiline 974-4
Epichlorohy- 203- 106-89-8 1.9
-
-
-
-
-
skin (10) -
drine
439-8
Ethylene
203- 106-93-4 0.8
0.1 -
-
-
-
skin (10) -
dibromide
444-5
1,3-Butadiene 203- 106-99-0 2.2
-
-
-
-
-
-
450-8
Ethylene
203- 107-06-2 8.2
-
-
-
-
skin (10) -
dichloride
458-1
Hydrazine
206- 302-01-2 0.013
0.01 -
-
-
-
skin (10) -
114-9
Bromoethyl- 209- 593-60-2 4.4
-
-
-
-
-
-
ene
800-6
Diesel engine -
-
0.05( * ) -
-
-
-
-
-
The limit
exhaust emis-
value shall
sions
apply from
21 Febru-
ary 2023.
For under-
ground
mining and
tunnel con-
struction
the limit
value shall
apply from
21 Febru-
ary 2026.
Polycyclic
-
-
-
-
-
-
-
-
skin (10) -
aromatic
hydrocarbons
mixtures, par-
ticularly those
containing
benzo[a]pyr-
ene, which
are carcino-
gens within
the meaning
of these regu-
lations
Mineral oils -
-
-
-
-
-
-
-
skin (10) -
that have been
used before in
internal com-
bustion
engines to
lubricate and
cool the mov-
ing parts
within the
engine
Cadmium and -
-
0.001( 11 ) -
-
-
-
-
-
Limit
its inorganic
value
compounds
0.004 mg/
m 3 ( 12 )
until 11
July 2027
Beryllium and -
-
0.0002
-
-
-
-
-
dermal Limit
inorganic
and res- value
( 11 )
beryllium
piratory 0.0006 mg/
compounds
sensitisa- m 3 until 11
tion ( 13 ) July 2026
Arsenic acid -
-
0.01 ( 11 ) -
-
-
-
-
-
For the
and its salts,
copper
as well as
smelting
inorganic
sector, the
arsenic com-
limit value
pounds
shall apply
from 11
July 2023
Formalde-
200- 50-00-0 0.37
0.3 -
0.7 0.6 -
dermal Limit
hyde
001-8
sensitisa- value
tion ( 14 ) 0.62 mg/
m 3 or 0.5
ppm ( 3 ) for
the health
care,
funeral and
embalm-
ing sectors
until 11
July 2024
4,4’-Methyl- 202- 101-14-4 0.01
-
-
-
-
-
skin ( )
ene-bis(2-
918-9
chloroaniline)
Acrylonitrile 203- 107-13-1 1
0.45 -
1.8 -
Skin ( 10 ) The limit
466-5
Dermal values shall
sensitisa- apply from
5 April
tion ( 14 )
2026. Nickel com- -
-
0.01 ( 15 ) -
-
-
-
-
Dermal The limit
pounds
and res- value ( 15 )
0.05 ( 16 )
piratory shall apply
sensitisa- from 18
tion ( 13 ) January
2025. The limit
value ( 16 )
shall apply
from 18
January
2025. Until
then a limit
value of
0.1 mg/m 3
( 16 ) shall
apply.
Inorganic lead -
-
0.15
-
-
-
-
-
-
-
and its com-
pounds
N,N-dimethy- 204- 127-19-5 36
-
72 20 -
Skin ( 10 ) -
lacetamide 826-4
Nitrobenzene 202- 98-95-3 1
0.2 -
-
-
-
Skin ( 10 ) -
716-0
N,N-
200- 68-12-2 15
-
30 10 -
Skin ( 10 ) -
Dimethylfor- 679-5
mamide
2-Methox-
203- 109-86-4 -
-
-
-
-
Skin ( 10 ) -
yethanol
713-7
2-Methox- 203- 110-49-6 -
-
-
-
-
Skin ( 10 ) -
yethyl acetate 772-9
2-Ethoxyetha- 203- 110-80-5 8
-
-
-
-
Skin ( 10 ) -
nol
804-1
2-Ethox-
203- 111-15-9 11
-
-
-
-
Skin ( 10 ) -
yethyl acetate 839-2
1-Methyl-2- 212- 872-50-4 40
-
80 20 -
Skin ( 10 ) -
pyrrolidone 828-1
Mercury and -
-
0.02
-
-
-
-
-
-
-
divalent inor-
ganic mercury
compounds
including
mercury
oxide and
mercury chlo-
ride (meas-
ured as
mercury)
Bisphenol A; 201- 80-05-7 2 ( 11 )
-
-
-
-
-
-
-
4,4'-Isopro- 245-8
pylidenedi-
phenol
Carbon mon- 211- 630-08-0 23
-
117 100 -
-
-
oxide
128-3
(1) EC No, i.e. EINECS, ELINCS or NLP, is the official number of the substance
within the European Union, as defined in Section 1.1.1.2 in Annex VI, Part 1, of Reg-
ulation (EC) No 1272/2008.
(2) CAS No: Chemical Abstract Service Registry Number.
(3) Measured or calculated in relation to a reference period of eight (8) hours time-
weighted average (TWA)
(4) Short-term exposure limit (STEL). A limit value above which exposure should
not occur and which is related to a 15-minute period unless otherwise specified.
(5) mg/m3 = milligrams per cubic metre of air at 20 °C and 101.3 kPa (760 mm mer-
cury pressure).
(6) ppm = parts per million by volume in air (ml/m3).
(7) f/ml = fibres per millilitre.
(8) Inhalable fraction: if hardwood dusts are mixed with other wood dusts, the limit
value shall apply to all wood dusts present in that mixture.
(9) Respirable fraction.
(10) Substantial contribution to the total body burden via possible dermal exposure
(11) Inhalable fraction
(12) Inhalable fraction. Respirable fraction in those Member States that implement,
on the date of the entry into force of this Directive, a monitoring system with a bio-
logical limit value not exceeding 0.002
mg Cd/g creatinine in urine.
(13) The substance can cause sensitisation of the skin and of the respiratory tract.
(14) The substance can cause sensitisation of the skin.
(15) Respirable fraction, measured as nickel.
(16) Inhalable fraction, measured as nickel.
(*) Measured as elemental carbon.
".
Immediately after Schedule III to the principal regulations
Adds new
there shall be added the following new Schedule IV
Schedule IV to
the principal
regulations.
"SCHEDULE IV
BIOLOGICAL LIMIT VALUES AND HEALTH
SURVEILLANCE MEASURES
(Regulation 16(3))
1. Lead and its ionic compounds
Biological monitoring shall include measuring the blood-
lead level (PbB) using absorption spectrometry or a method
giving equivalent results. The binding biological limit value is
70 μg Pb/100 ml blood
Medical surveillance is carried out if exposure to a
concentration of lead in air is greater than 0.075 mg/m 3 ,
calculated as a time-weighted average over forty (40) hours per
week, or a blood-lead level greater than 40 μg Pb/100 ml blood is
measured in individual workers.".
€1.62